Literature DB >> 28540422

Loss and remodeling of striatal dendritic spines in Parkinson's disease: from homeostasis to maladaptive plasticity?

Rosa M Villalba1,2, Yoland Smith3,4,5.   

Abstract

In Parkinson's disease (PD) patients and animal models of PD, the progressive degeneration of the nigrostriatal dopamine (DA) projection leads to two major changes in the morphology of striatal projection neurons (SPNs), i.e., a profound loss of dendritic spines and the remodeling of axospinous glutamatergic synapses. Striatal spine loss is an early event tightly associated with the extent of striatal DA denervation, but not the severity of parkinsonian motor symptoms, suggesting that striatal spine pruning might be a form of homeostatic plasticity that compensates for the loss of striatal DA innervation and the resulting dysregulation of corticostriatal glutamatergic transmission. On the other hand, the remodeling of axospinous corticostriatal and thalamostriatal glutamatergic synapses might represent a form of late maladaptive plasticity that underlies changes in the strength and plastic properties of these afferents and the resulting increased firing and bursting activity of striatal SPNs in the parkinsonian state. There is also evidence that these abnormal synaptic connections might contribute to the pathophysiology of L-DOPA-induced dyskinesia. Despite the significant advances made in this field over the last thirty years, many controversial issues remain about the striatal SPN subtypes affected, the role of spine changes in the altered activity of SPNs in the parkinsonisn state, and the importance of striatal spine plasticity in the pathophysiology of L-DOPA-induced dyskinesia. In this review, we will examine the current state of knowledge of these issues, discuss the limitations of the animal models used to address some of these questions, and assess the relevance of data from animal models to the human-diseased condition.

Entities:  

Keywords:  Corticostriatal; Dopamine; Glutamate; Monkey; Striatum; Thalamostriatal

Mesh:

Year:  2017        PMID: 28540422      PMCID: PMC5701884          DOI: 10.1007/s00702-017-1735-6

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  168 in total

1.  Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats.

Authors:  M S Aymerich; P Barroso-Chinea; M Pérez-Manso; A M Muñoz-Patiño; M Moreno-Igoa; T González-Hernández; J L Lanciego
Journal:  Eur J Neurosci       Date:  2006-04       Impact factor: 3.386

2.  Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines.

Authors:  T F Freund; J F Powell; A D Smith
Journal:  Neuroscience       Date:  1984-12       Impact factor: 3.590

3.  Evidence of a breakdown of corticostriatal connections in Parkinson's disease.

Authors:  B Stephens; A J Mueller; A F Shering; S H Hood; P Taggart; G W Arbuthnott; J E Bell; L Kilford; A E Kingsbury; S E Daniel; C A Ingham
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

4.  Synapses between interneurons in the lateral geniculate nucleus of monkeys.

Authors:  P Pasik; T Pasik; J Hámori
Journal:  Exp Brain Res       Date:  1976-05-10       Impact factor: 1.972

5.  Dopaminergic regulation of olfactory type G-protein α subunit expression in the striatum.

Authors:  I Ruiz-DeDiego; J R Naranjo; D Hervé; R Moratalla
Journal:  Mov Disord       Date:  2015-03-15       Impact factor: 10.338

6.  Interaction between hyperdirect and indirect basal ganglia pathways.

Authors:  Stella M Papa; Thomas Wichmann
Journal:  Mov Disord       Date:  2015-05-28       Impact factor: 10.338

7.  Three-dimensional relationships between perisynaptic astroglia and human hippocampal synapses.

Authors:  Mark R Witcher; Yong D Park; Mark R Lee; Suash Sharma; Kristen M Harris; Sergei A Kirov
Journal:  Glia       Date:  2010-04       Impact factor: 7.452

8.  Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses.

Authors:  M Xu; R Moratalla; L H Gold; N Hiroi; G F Koob; A M Graybiel; S Tonegawa
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

9.  A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals.

Authors:  Jonathan Moss; J Paul Bolam
Journal:  J Neurosci       Date:  2008-10-29       Impact factor: 6.167

10.  Counting Synapses Using FIB/SEM Microscopy: A True Revolution for Ultrastructural Volume Reconstruction.

Authors:  Angel Merchán-Pérez; José-Rodrigo Rodriguez; Lidia Alonso-Nanclares; Andreas Schertel; Javier Defelipe
Journal:  Front Neuroanat       Date:  2009-10-05       Impact factor: 3.856

View more
  24 in total

Review 1.  Synaptic plasticity may underlie l-DOPA induced dyskinesia.

Authors:  Anders Borgkvist; Ori J Lieberman; David Sulzer
Journal:  Curr Opin Neurobiol       Date:  2017-11-07       Impact factor: 6.627

2.  NMDA receptor blockade ameliorates abnormalities of spike firing of subthalamic nucleus neurons in a parkinsonian nonhuman primate.

Authors:  Subhrajit Bhattacharya; Yuxian Ma; Amy R Dunn; Joshua M Bradner; Annalisa Scimemi; Gary W Miller; Stephen F Traynelis; Thomas Wichmann
Journal:  J Neurosci Res       Date:  2018-03-25       Impact factor: 4.164

3.  Role of striatal ΔFosB in l-Dopa-induced dyskinesias of parkinsonian nonhuman primates.

Authors:  Goichi Beck; Arun Singh; Jie Zhang; Lisa F Potts; Jong-Min Woo; Eun S Park; Hideki Mochizuki; M Maral Mouradian; Stella M Papa
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-27       Impact factor: 11.205

4.  A Selective Phosphodiesterase 10A Inhibitor Reduces L-Dopa-Induced Dyskinesias in Parkinsonian Monkeys.

Authors:  Goichi Beck; Shunsuke Maehara; Phat Ly Chang; Stella M Papa
Journal:  Mov Disord       Date:  2018-03-06       Impact factor: 10.338

5.  Differential Synaptic Remodeling by Dopamine in Direct and Indirect Striatal Projection Neurons in Pitx3-/- Mice, a Genetic Model of Parkinson's Disease.

Authors:  Luz M Suarez; Samuel Alberquilla; Jose R García-Montes; Rosario Moratalla
Journal:  J Neurosci       Date:  2018-02-26       Impact factor: 6.167

6.  Thalamic degeneration in MPTP-treated Parkinsonian monkeys: impact upon glutamatergic innervation of striatal cholinergic interneurons.

Authors:  Rosa M Villalba; Jean-Francois Pare; Solah Lee; Sol Lee; Yoland Smith
Journal:  Brain Struct Funct       Date:  2019-11-02       Impact factor: 3.270

7.  Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease.

Authors:  Rhyomi C Sellnow; Kathy Steece-Collier; Feras Altwal; Ivette M Sandoval; Jeffrey H Kordower; Timothy J Collier; Caryl E Sortwell; Anthony R West; Fredric P Manfredsson
Journal:  J Neurosci       Date:  2020-04-01       Impact factor: 6.167

8.  Non-human primate research of basal ganglia and movement disorders: advances and challenges.

Authors:  Yoland Smith; Adriana Galvan
Journal:  J Neural Transm (Vienna)       Date:  2018-03       Impact factor: 3.575

9.  Early decreases in cortical mid-gamma peaks coincide with the onset of motor deficits and precede exaggerated beta build-up in rat models for Parkinson's disease.

Authors:  Elena Brazhnik; Nikolay Novikov; Alex J McCoy; Neda M Ilieva; Marian W Ghraib; Judith R Walters
Journal:  Neurobiol Dis       Date:  2021-05-15       Impact factor: 5.996

10.  Comparative Ultrastructural Analysis of Thalamocortical Innervation of the Primary Motor Cortex and Supplementary Motor Area in Control and MPTP-Treated Parkinsonian Monkeys.

Authors:  Rosa M Villalba; Joseph A Behnke; Jean-Francois Pare; Yoland Smith
Journal:  Cereb Cortex       Date:  2021-06-10       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.